Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-15-0093-t
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Combining ROR1- Specific Chimeric Antigen Receptor (CAR) NK Cells With IL-15 Superagonist (N-803/Alt-803) to Target Chemotherapy Resistant Neuroblastoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

The IL-15 Superagonist ALT-803 Enhances Anti-Cd20 Antibody-Directed NK Cell ADCC and in Vivo Clearance of B Cell Lymphomas

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Combining Dinutuximab With ALT-803 (IL-15 Superagonist) Significantly Improves the Activity of Ex Vivo Expanded Natural Killer Cells Against GD2 + Pediatric Solid Tumors (ST)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Animal Models of Cancer Pain

Neuromethods
Mental HealthGeneticsPharmacologyMolecular BiologyBiochemistryNeurosciencePsychiatryToxicologyPharmaceutics
2010English

Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2015English

Animal Cancer Models of Skeletal Metastasis

Cancer Growth and Metastasis
2013English

MicroRNAs as Novel Immunotherapeutics

OncoImmunology
OncologyAllergyImmunology
2013English

Animal Models to Study Cancer-Initiating Cells From Glioblastoma

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2011English

Enhancing the Functional Activity of Natural Killer Cells Against Myeloid Leukemia With the IL-15 Super-Agonist, ALT-803

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy